ES2001783A6 - Procedimiento para la obtencion de un antibiotico macrociclico - Google Patents

Procedimiento para la obtencion de un antibiotico macrociclico

Info

Publication number
ES2001783A6
ES2001783A6 ES8601870A ES8601870A ES2001783A6 ES 2001783 A6 ES2001783 A6 ES 2001783A6 ES 8601870 A ES8601870 A ES 8601870A ES 8601870 A ES8601870 A ES 8601870A ES 2001783 A6 ES2001783 A6 ES 2001783A6
Authority
ES
Spain
Prior art keywords
macrocyclic antibiotics
hydroxy
compounds
macrocyclic
antibiotics
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES8601870A
Other languages
English (en)
Inventor
Hans Reighenbach
Gerhard Hofle
Hermann Augustiak
Norbert Bedorf
Klaus Gerth
Herbert Irschik
Rolf Janse
Brigitte Kunze
Dietmar Schomburg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Helmholtz Zentrum fuer Infektionsforschung HZI GmbH
Original Assignee
Ciba Geigy AG
Helmholtz Zentrum fuer Infektionsforschung HZI GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG, Helmholtz Zentrum fuer Infektionsforschung HZI GmbH filed Critical Ciba Geigy AG
Publication of ES2001783A6 publication Critical patent/ES2001783A6/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/22—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides
    • C12P19/60—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • C12P19/62—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin
    • C12P19/623—Avermectin; Milbemycin; Ivermectin; C-076

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE UN ANTIBIOTICO MACROCICLICO DE FORMULA DONDE R1 SIGNIFICA HIDROGENO, O HIDROXI Y R2 SIGNIFICA HIDROXI O BETA-GLUCOPIRANOSILOXI, LOS SOLVATOS Y LAS SALES DE TALES COMPUESTOS, ESPECIALMENTE LAS SALES FARMACEUTICAMENTE UTILIZABLES. LOS COMPUESTOS (I) SE OBTIENEN FERMENTATIVAMENTE EMPLEANDO LA CEPA SO CE 12 (NCIB 12134) DE LA ESPECIE SORANGIUM CELLULOSUM Y TIENEN UNA EFICACIA ANTIBIOTICA.
ES8601870A 1985-09-13 1986-09-12 Procedimiento para la obtencion de un antibiotico macrociclico Expired ES2001783A6 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH398685 1985-09-13

Publications (1)

Publication Number Publication Date
ES2001783A6 true ES2001783A6 (es) 1988-06-16

Family

ID=4267667

Family Applications (1)

Application Number Title Priority Date Filing Date
ES8601870A Expired ES2001783A6 (es) 1985-09-13 1986-09-12 Procedimiento para la obtencion de un antibiotico macrociclico

Country Status (9)

Country Link
US (2) US4987072A (es)
EP (1) EP0216731B1 (es)
JP (1) JPS62181281A (es)
AT (1) ATE51003T1 (es)
DE (1) DE3669515D1 (es)
DK (1) DK162390C (es)
ES (1) ES2001783A6 (es)
GR (1) GR862324B (es)
PT (1) PT83356B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0358608A3 (de) * 1988-09-09 1990-10-31 Gesellschaft für Biotechnologische Forschung mbH (GBF) Mikrobizide makrozyklische Laktonderivate
EP0358606A3 (de) * 1988-09-09 1990-10-31 Gesellschaft für Biotechnologische Forschung mbH (GBF) Mikrobiologisches Verfahren zur Herstellung agrarchemisch verwendbarer mikrobizider makrozyklischer Lactonderivate
EP0358607A3 (de) * 1988-09-09 1990-10-31 Gesellschaft für Biotechnologische Forschung mbH (GBF) Mikrobizide makrozyklische Laktonderivate
DE3930950A1 (de) * 1989-09-15 1991-03-28 Biotechnolog Forschung Gmbh Synthetische sorangicin-varianten und herstellungsverfahren
US5393897A (en) * 1993-07-02 1995-02-28 Arizona Board Of Regents Acting On Behalf Of Arizona State University Isolation and structure of spongistatins 5,7,8 and 9
US5380838A (en) * 1993-10-08 1995-01-10 Merck & Co. Inc. Stable solvates of avermectin compounds
US5478861A (en) * 1994-02-18 1995-12-26 Harbor Branch Oceanographic Institution, Inc. Cytotoxic macrolides and methods of use
US5684036A (en) * 1994-02-18 1997-11-04 Harbor Branch Oceanographic Institution, Inc. Cytotoxic macrolides and methods of use
US6194181B1 (en) * 1998-02-19 2001-02-27 Novartis Ag Fermentative preparation process for and crystal forms of cytostatics
TWI291464B (en) * 2002-09-23 2007-12-21 Bristol Myers Squibb Co Methods for the preparation, isolation and purification of epothilone B, and X-ray crystal structures of epothilone B
JP2010110216A (ja) * 2007-02-20 2010-05-20 Ajinomoto Co Inc Ｌ−アミノ酸または核酸の製造方法
EP3498714B1 (en) 2017-12-14 2020-07-22 Helmholtz-Zentrum für Infektionsforschung GmbH Novel sorangicin antibiotic

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3651216A (en) * 1970-05-11 1972-03-21 Warner Lambert Co Antibiotic substances produced by polyangium cellulosum var. fulvum
DE3700331A1 (de) * 1986-12-24 1988-07-07 Hoechst Ag Verfahren zur herstellung der desmalonylverbindung von makrolid-lactonen

Also Published As

Publication number Publication date
DK162390B (da) 1991-10-21
PT83356A (en) 1986-10-01
DK162390C (da) 1992-03-09
EP0216731B1 (de) 1990-03-14
DK437886A (da) 1987-03-14
US5096922A (en) 1992-03-17
JPS62181281A (ja) 1987-08-08
DE3669515D1 (de) 1990-04-19
PT83356B (pt) 1989-05-12
US4987072A (en) 1991-01-22
ATE51003T1 (de) 1990-03-15
DK437886D0 (da) 1986-09-12
EP0216731A1 (de) 1987-04-01
GR862324B (en) 1987-01-12

Similar Documents

Publication Publication Date Title
EP0205165A3 (en) Molybdenum-containing lubricant composition
GB9514473D0 (en) Chemical compounds
UA5953A1 (uk) Спосіб отримання похідних сульфонілмочевин
EP0247167A4 (en) HYDROXY AND AMINOTHIAZOLYL-BENZODIAZINONE COMPOUNDS, CARDIOTONIC COMPOSITIONS CONTAINING THEM AND THEIR USES.
ES2001783A6 (es) Procedimiento para la obtencion de un antibiotico macrociclico
EP0177940A3 (en) Hydrazine derivatives and their use
GB2165237B (en) 1,3-oxazolidine-2-one derivatives
IL75018A0 (en) Chartreusin derivatives,salts thereof,antitumorous compositions containing the same,and processes for producing the same
AP8800109A0 (en) "Heterocyclic insecticides".
ES8701737A1 (es) Un procedimiento para la preparacion de nuevas quinazolindionas.
DE3475073D1 (en) Azahomoerythromycin b derivatives and intermediates thereof
ES8205214A1 (es) Un procedimiento para la preparacion de un derivado de 3-o- desmetilsannamicina c o del antibiotico ax-127b-1.
CA1265131C (en) ERYTHROMYCYLAMINE DERIVATIVES
IE820199L (en) Dibenzofuran derivatives
ES470429A1 (es) Un metodo para preparar pseudotriscaridos
EP0357109A3 (en) Platinum-(ii)-diamine complex, method for the preparation of this compound, preparation with an anti-tumour action which contains this compound and also shaped preparations with an anti-tumour action
EP0612750A3 (en) Cephalosporinderivatives.
GR852224B (es)
DE3376833D1 (en) Derivatives of 7-oxo-4-oxa-diazabicyclo-(3.2.0)-hept-2-en not substituted in position 6, processes for their preparation and their use as intermediates in the synthesis of beta-lactam antibiotics
AR245225A1 (es) Composiciones para el tratamiento de cuero.
IT1211678B (it) Minispruzzatore rotativo per irrigazione
SU1132513A1 (ru) 2-метиламино-4-оксо-3,6,6-триметил-5,6-дигидро-8н-пирано[4′,3′ : 4,5]тиено[2,3-d]пиримидин или его соли, обладающие противосудорожной активностью
DE3062286D1 (en) 9-chloro-prednisolone derivatives, their preparation and their utilization
SU1241748A1 (ru) Способ разработки нефтяного месторождения
ES8301486A1 (es) Nuevos derivados 1-n-(x-hidroxi-w-aminoalcanoil)de 5,3'4'- tridesoxi-o 5,3,4'-tridesoxi-6'-n-metil-o 5,3',4',6 -tetra- desoxi-kanamicina b y produccion de los mismos

Legal Events

Date Code Title Description
SA6 Expiration date (snapshot 920101)

Free format text: 2006-09-12